Global  

Drug touted by Trump as COVID-19 treatment tied to increased risk of death -study

Reuters India Friday, 22 May 2020
The malaria drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to increased risk of death in hospitalized COVID-19 patients, according to a large study published in the medical journal Lancet.
0
shares
ShareTweetSavePostSend
 

You Might Like


Related videos from verified sources

FDA Warns Consumers Over These Hand Sanitizers It Says Are Considered Toxic [Video]

FDA Warns Consumers Over These Hand Sanitizers It Says Are Considered Toxic

The Food and Drug Administration is adding to its list of hand sanitizers that it deems toxic given that they contain methanol. Veuer’s Justin Kircher has the story.

Credit: Veuer     Duration: 00:54Published
FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim [Video]

FDA Commissioner Won't Confirm Or Deny Trump's Unfounded COVID-19 Claim

The commissioner of the US Food and Drug Administration on Sunday didn't defend a claim recently made by President Donald Trump. But according to CNN, he didn't support it, either. Dr. Stephen Hahn is..

Credit: Wochit News     Duration: 00:45Published
Grandparents Raising Grandkids Are In An Impossible Situation [Video]

Grandparents Raising Grandkids Are In An Impossible Situation

The opioid crisis left roughly 2.4 million grandparents across the US with the responsibility of raising their grandchildren. But with the novel coronavirus COVID-19 pandemic, the ones protecting their..

Credit: Wochit Tech     Duration: 00:45Published

Related news from verified sources

Hydroxychloroquine tied to increased risk of death: Study

Coronavirus patients taking the anti-malarial drug, touted and taken by Trump, had higher risk of death, new study says.
Al Jazeera Also reported by •ReutersWorldNewsReuters IndiaJerusalem PostNew Zealand HeraldThe AgeIndependentSeattle TimesMediaite

Anti-malarial drug taken by Donald Trump linked to death risk

A study in the medical journal The Lancet has linked the malaria drug hydroxychloroquine to a higher risk of death in COVID-19 patients.
SBS Also reported by •ReutersReuters IndiaJerusalem PostNew Zealand HeraldThe AgeIndependentSeattle TimesCBS News

Algernon Pharmaceuticals closes special warrants offering that raised nearly C$7M

Algernon Pharmaceuticals Inc (CSE: AGN) (OTCQB:AGNPF) announced Wednesday it closed a private placement offering of special warrants that raised nearly C$7...
Proactive Investors


Tweets about this